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Epithelial–mesenchymal transitionMesoderm formation in the mouse embryo initiates around E6.5 at the primitive streak and
continues until the end of axis extension at E12.5. It requires the process of epithelial-to-
mesenchymal transition (EMT), wherein cells detach from the epithelium, adopt mesen-
chymal cell morphology, and gain competence to migrate. It was shown previously that,
prior to mesoderm formation, the transcription factor SRF (Serum Response Factor) is
essential for the formation of the primitive streak. To elucidate the role of murine Srf in
mesoderm formation during axis extension we conditionally inactivated Srf in nascent
mesoderm using the T(s)::Cre driver mouse. Defects in mutant embryos became apparent
at E8.75 in the heart and in the allantois. From E9.0 onwards body axis elongation was
arrested. Using genome-wide expression analysis, combined with SRF occupancy data
from ChIP-seq analysis, we identified a set of direct SRF target genes acting in posterior
nascent mesoderm which are enriched for transcripts associated with migratory function.
We further show that cell migration is impaired in Srf mutant embryos. Thus, the primary
role for SRF in the nascent mesoderm during elongation of the embryonic body axis is the
activation of a migratory program, which is a prerequisite for axis extension.
 2014 Elsevier Ireland Ltd. All rights reserved.1. Introduction Cells located in the ps differentiate into mesendodermalDuring vertebrate development the embryonic body grows
in an anterior to posterior direction. Elongation of the antero-
posterior (A–P) axis depends on the progressive addition of
new tissue at the posterior end of the embryo, which is gen-
erated by a transient structure called the primitive streak
(ps). In mouse embryos, the ps forms at embryonic day (E)
6.5 and is replaced by the tail bud at mid-somite stages
(E9.25–E9.5, P22 somites) (for review, see Beddington, 1983).tissue, marked by the expression of genes such as Brachyury
(T) (Herrmann, 1991). These cells undergo an epithelial-to-
mesenchymal transition (EMT), allowing them to become
motile, migrate away from the ps, and intercalate between
the definitive endoderm and ectoderm (reviewed in Baum
et al., 2008). Epithelial epiblast cells provide a constant source
of mesodermal cells. At E7.5 a complete layer of mesoderm
has formed between the ectoderm and endoderm, but EMT
continues until axis elongation ceases between E12.5 and
E13.5 (Cunningham et al., 2011).
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stages of embryonic development including gastrulation,
neural crest formation, and heart morphogenesis (Lim and
Thiery, 2012). Moreover, the essential role of EMT in tumor
metastasis has been well studied. EMT is a multistep process
that comprises the degradation of cell–cell contact proteins
(e.g., E-cadherin), the breakdown of the basement membrane,
and the regulation of cytoskeletal reorganization (Nakaya and
Sheng, 2008; Levayer and Lecuit, 2008). As a consequence,
mesenchymal cells lose contact with their neighboring cells,
which is a prerequisite for migratory capacity, and they adopt
a more extended and elongated shape.
The molecular basis that underlies EMT during mouse gas-
trulation is only partly understood. Genetic studies in mice
have demonstrated that FGF induces downregulation of E-
cadherin in ps cells, both at the transcriptional and post-tran-
scriptional levels (Ciruna and Rossant, 2001; Zohn et al., 2006),
thereby inducing the delamination of cells from the epithe-
lium. In addition to FGF, several other extracellular signaling
molecules contribute to EMT in generating mesodermal cells,
including members of the Wnt and TGFb families (Ben-Haim
et al., 2006; Kemler et al., 2004). It has also been shown that
Wnt signaling is required to specify a pool of multipotent
stem cells in the caudal region of vertebrate embryos
(Martin and Kimelman, 2012), and that these axial stem cells
are required for vertebrate axis extension (for review see
Wilson et al., 2009). The molecular characterization of these
stem cells is pending, but it is already established that Sox
genes are involved in their function (Yoshida et al., 2014).
The gene encoding the transcription factor Serum
Response Factor (SRF) is expressed in the ps and newly
formed mesoderm in several vertebrates at early stages of
gastrulation (Barron et al., 2005; Croissant et al., 1996;
Mohun et al., 1991), but its role during mesoderm develop-
ment and axis elongation has not received careful investiga-
tion. SRF is a homodimeric MADS-box-containing
transcription factor, which binds a 10 bp sequence known
as the CArG box (Norman et al., 1988; Shore and Sharrocks,
1995). More than 170 bona fide SRF target genes have been
identified (reviewed in Miano, 2008). These mainly comprise
genes involved in muscle cell differentiation, as well as the
regulation of cell growth, cell survival, and cell motility
(Johansen and Prywes, 1995; Miano, 2003).
Srf/ mouse embryos show severe gastrulation defects,
including lack of the ps, and die at mid-gestation (Arsenian
et al., 1998). Srf mutants lack all mesodermal tissue and begin
to be resorbed from stage E8.5 onwards. While these data
identified SRF as a regulator of mesoderm induction, they
did not provide insight into the role that SRF plays once the
ps has formed. Thus, in order to study the role of SRF during
axis elongation, we conditionally deleted Srf in murine ps
cells using Cre recombinase driven by the Brachyury (T) pro-
moter region responsible for T expression in the ps (T(s)::Cre)
(Feller et al., 2008). The resulting mutant embryos displayed,
amongst other defects, severe axis truncation – indicating
that SRF is essential for axis elongation. We present both
molecular and functional data to demonstrate that SRF is
required for mesodermal cell migration during axis elonga-
tion. This identifies SRF as a main player in the EMT processduring gastrulation and the subsequent mesodermal cell
movements that are essential for axis elongation.
2. Results
2.1. Conditional deletion of Srf in Brachyury-expressing
cells causes an arrest of axis elongation
In order to investigate the role of SRF during trunk devel-
opment, we first analyzed its expression pattern in mid-
gestational embryos. Whole mount in situ hybridization of
E9.5 mouse embryos showed domains of increased Srf expres-
sion in the forebrain, the branchial arches, the intermediate
mesoderm and in the paraxial mesoderm and caudal end
(Fig. 1A). Expression of Srf in nascent mesodermal tissue
(such as the paraxial mesoderm) suggested a possible role
in mesoderm development during axis elongation. To analyze
the function of SRF in nascent mesoderm we generated
mouse embryos lacking Srf in that tissue using the Cre/loxP
system. Brachyury (T) is one of the earliest markers of meso-
derm during development (Herrmann, 1991), thus, we crossed
the Srfflex1/flex1 mouse line carrying a loxP flanked exon one of
Srf (Wiebel et al., 2002) with the T(s)::Cre (C57Bl/6JTg(T-cre)1Gos)
line expressing Cre recombinase under control of the Tstreak
promoter of T, comprised of the 600 bp upstream of the ATG
codon (Feller et al., 2008). This results in a reduction of Srf
in anterior mesoderm of E8.5 embryos and a complete loss
Srf expression in posterior mesodermal tissue (Fig. 2B).
The morphology of Srfflex1/flex1; T(s)::Cre embryos was indis-
tinguishable from wild type embryos until E8.5, but at E8.75
embryos showed malformations of the heart, the allantois,
and had an overall smaller appearance (Fig. 1C and D). At
E9.5, axis elongation in the mutants had been fully arrested,
demonstrating an essential function for SRF in this process.
At E10.5 no viable Srfflex1/flex1; T(s)::Cre embryos were observed.
The role of SRF in heart development has already been
described (Parlakian et al., 2004), and abnormalities of the
heart and allantois, resulting in defective nutrient and gas
exchange, are the likely cause of death in the current model.
In addition, this phenotype is in full agreement with previ-
ously observed impairment of mesoderm formation upon
constitutive Srf deletion (Arsenian et al., 1998).
2.2. Mesenchymal character is not impaired in cells of the
Srfflex1/flex1; T(s)::Cre embryo caudal end
The arrest of axis elongation observed here could be
caused by the loss of mesoderm cells, therefore differing from
Wnt3a or Brachyury mutant embryos where mesoderm induc-
tion and formation is impaired (Takada et al., 1994; Wilkinson
et al., 1990). In order to investigate this possibility we tested
for the presence of BRACHYURY-positive cells in Srf mutant
embryos by immunohistochemistry. Srf mutants have a sig-
nificant number of BRACHYURY positive cells, indicating that
mesoderm is indeed formed upon loss of SRF in cells
progressing through the ps (Fig. 2A). An early hallmark of
mesoderm formation is the initiation of EMT in the ps accom-
panied by loss of the cell surface marker E-cadherin. In Srf
mutants EMT seems to be initiated, as E-cadherin is present
Fig. 1 – Brachyury(T)-driven loss of SRF results in arrest of axis elongation. (A) Whole mount in situ hybridization of Srf in a
wild type mouse embryo at E9.5. Srf transcript is widespread, but strong expression can be observed in the fronto-nasal
process, the maxillo-mandibular cleft and first branchial arch, the intermediate mesoderm, and the paraxial mesoderm in
the caudal region of the embryo (indicated by the dashed line) up to the forming somitomeres (indicated by arrowheads). (B)
Srf transcript is reduced in Srfflex1/flex1; T(s)::Cre Embryos in all mesodermal derived tissues and not detectable in the posterior
mesodermal tissues even after prolonged staining. Scale bar = 500 lm. (C) Srfflex1/+; T(s)::Cre embryos at E8.75 and E9.5 exhibit
a normally extended antero-posterior axis (indicated by red line). (D) Srfflex1/flex1; T(s)::Cre embryos (E8.75 and E9.5) display
malformations in the heart (arrow) and the allantois (arrowhead). At E8.75, they have a normally extended antero-posterior
axis, while at E9.5, they display axis truncation (indicated by the dashed line), among other developmental defects.
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mesodermal cells of the caudal end (Fig. 2A). In addition,
the mesenchymal marker Vimentin could be detected in the
early mesoderm (Fig. 2A), further demonstrating that these
cell have undergone EMT.
SRF was previously shown to promote cell survival in
embryos by inhibiting apoptosis (Schratt et al., 2004). We
quantitatively assessed the number of apoptotic cells by
counting Annexin V positive cells that were not necrotic (PI
positive) in heads and caudal ends from single SRF mutants
or control embryos by flow cytometry. In heads and caudal
ends from E8.75 (TS13/14) control embryos we could detect
10.4% ± 1.8% and 10.5% ± 1.7% apoptotic cells, respectively
(Fig. 2C and D). In SRF mutants the number of apoptotic cells
in heads and caudal ends increased to 34.5% ± 1.0% and
23.7% ± 1.5%, respectively (Fig. 2C and D). We also measured
the number of mitotic cells by staining for histone 3 serine
10 phosphorylation (H3S10P) and were not able to detect
any changes (Fig. 2E and F). The increase in the number of
apoptotic cells might explain the overall smaller appearance
of the SRF mutant embryos, but is not sufficient to explain
the axis truncation defect.
2.3. RNA expression and ChIP data identified 25 direct
SRF target genes during axis elongation
To elucidate the molecular mechanism behind the
observed axis truncation phenotype, we dissected posterior
ends composed of late ps and unsegmented, nascent meso-derm from Srfflex1/flex1; T(s)::Cre embryos and their heterozy-
gous littermates. We examined gene expression at three
distinct stages: (i) before malformations in the mutants
became apparent (E8.5; 3–9 somites), (ii) when heart and
allantoic malformations were visible, but before axis trunca-
tion was apparent (E8.75; 11–13 somites), and (iii) when axis
elongation arrested (E9.0; 14–16 somites). As expected, Srf
was downregulated at all three stages (Fig. 3), demonstrating
that Srf is effectively inactivated in caudal mesoderm by
T(s)::Cre activity. Coincident with the observed increasing
severity of the mutant phenotype, the total number of dysreg-
ulated genes increased from 10 genes at E8.5 to 139 genes at
E8.75 and 439 genes at E9.0 (fold changeP log20.4, p 6 0.05;
n = 4) (Table 1).
To distinguish between direct and indirect targets of SRF
during the process of axis extension, we used a genome-wide
approach to search for genomic regions bound by SRF, via
chromatin immunoprecipitation (ChIP). Chromatin was
derived from P19 mouse embryonal carcinoma cells engi-
neered to stably overexpress Srf. P19 cells are pluripotent
and thus able to differentiate into derivatives of all three germ
layers (McBurney, 1993). They are reminiscent of epiblast cells
from the early post-implantation blastocyst, and are often
used to study events occurring during gastrulation (van der
Heyden and Defize, 2003; Yeom et al., 1996).
ChIP-seq analysis identified SRF-bound genomic regions
throughout the genome. Previous work demonstrated that
the vast majority of SRF binding sites reside within 4000 bp
from the transcriptional start site (TSS) of a regulated gene
Fig. 2 – Mesoderm formation in Srfflex1/flex1; T(s)::Cre embryos. Immunohistological analysis on sagittal sections of caudal ends
from E9.0 Srfflex1/flex1; T(s)::Cre and control Srfflex1/+; T(s)::Cre littermates. (A) Nascent mesoderm and epithelial cells were
immunostained for BRACHYURY, E-cadherin and Vimentin. Sections were counterstained with DAPI to visualize nuclei.
Arrows indicate the epithelial E-cadherin signal and the mesenchymal Vimentin signal, respectively. The scale bar
represents 50 lm. (B) Representative flow cytometry analysis of Annexin V (apoptotic) and PI positive (necrotic) cells from
single caudal ends isolated from early E9.0 embryos. The two contour scatterplots depict 3117 (left) and 3066 (right) single cell
events and the percentages of cells that fall into the given gate. (C) Quantification of apoptotic cells (n = 3) from heads and
caudal ends of single embryos. The standard deviation (s.d.) is given. (D) Representative immunostaining of H3S10P indicates
mitotic cells in sagittal sections of caudal region of embryos at E9.0. (E) Quantification of the number of mitotic (H3S10P) to the
number of total cells (DAPI) in presomitic mesoderm from three consecutive sections from two different embryos. The s.d. is
given.
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Fig. 3 – Direct target genes of SRF during axial elongation. Identification of direct SRF target genes which are dysregulated in
caudal ends of Srfflex1/flex1; T(s)::Cre embryos. The heat map indicates the degree of dysregulation at E8.5, E8.75 and E9.0.
References are given for genes that have been previously identified as SRF targets. The position of SRF enrichment peaks
identified in P19 cells is indicated with respect to the transcriptional start site (TSS). [n.d. = not detectable.] (See above-
mentioned references for further information.)
Table 1 – Number of significantly dysregulated genes in Srfflex1/flex1; T(s)::Cre embryo caudal ends (p 6 0.05).
Stage E8.5 E8.75 E9.0 Combined
Phenotype None Mild Strong
# of genes bound by SRF/total dysregulated genes (%)
Downregulated genes 6/7 (85.7%) 10/26 (38.5%) 15/216 (6.9%) 19/230 (8.3%)
Upregulated genes 0/3 (0.0%) 3/113 (2.7%) 4/223 (1.8%) 6/316 (1.9%)
Total dysregulated genes 6/10 (60.0%) 13/139 (38.5%) 19/436 (6.9%) 25/546 (8.3%)
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genomic distances. Among the over 19,100 genes represented
on the microarray we identified 658 genes (p-value 6 1 · 105)
containing one or more SRF peaks within 4000 bp of the TSS.
Among these 658 genes, only 18 genes were differentially
expressed between Srfflex1/flex1; T(s)::Cre embryos and heterozy-
gous control embryos at all stages examined. Of those 18
genes, 12 (including Srf) have previously been described as
SRF target genes, and six are novel putative Srf targets
(Fig. 3). In addition, we identified seven genes which showeddifferential expression in the microarray analysis, and have
previously been shown to be bound by SRF in other cell types,
but were not found to be bound by SRF in P19 cells. Taken
together, we identified 25 genes that are bound by SRF and
are dysregulated in the caudal ends of Srfflex1/flex1; T(s)::Cre
embryos. Of these 25 direct SRF target genes we found 19 to
be downregulated in the absence of Srf, whereas only six were
found to be upregulated. This is consistent with previous
reports suggesting that SRF mainly acts as a transcriptional
activator (Schlesinger et al., 2011).
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Fig. 4 – Validation of dysregulation of SRF target genes in
Srfflex1/flex1; T(s)::Cre caudal ends. Quantitative real-time PCR
analysis of a subset of SRF target genes. Expression levels
were analyzed in E8.75–E9.0 caudal ends of Srfflex1/flex1;
T(s)::Cre compared to Srfflex1/+; T(s)::Cre embryos (control)
(s.d., n = 3, p 6 0.05) and normalized to the housekeeping
genes Gapdh and Hmbs.
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on a subset of the SRF targets acting during axis elongation
(Fig. 4). The qRT-PCR data confirmed the microarray data,
suggesting that all 25 genes identified in this work are depen-
dent on Srf during the process of axis elongation.
While the overall number of genes directly regulated by
SRF increased over the three stages analyzed (E8.5 = 6,
E8.75 = 13 and E9.0 = 19) their percentage with respect to the
total number of dysregulated genes decreased (E8.5 = 60%,
E8.75 = 9.4% and E9.0 = 4.3%) (Table 1). It is likely that the
increase in dysregulated genes is due to altered tissue compo-
sition of later stage Srf-deficient embryos, rather than reflect-
ing an increase in the number of SRF target genes at later
stages. Hence, the SRF targets found here are those most
likely to be causal for the axis elongation defect observed in
Srf-deficient embryos.
2.4. SRF controls cell migration during axis elongation
In order to elucidate the primary function of the 25 direct
SRF targets identified in the process of axis extension, we per-
formed Gene Ontology analysis (Ingenuity Pathway AnalysisTable 2 – Main cellular functions of genes regulated by Srf durin
Category p-Value range # O
Cellular movement 7.16 · 108–4.84 · 102 16
Cell Morphology 2.43 · 107–4.45 · 102 12
Cellular assembly and organization 2.12 · 106–4.86 · 102 16
Cellular function and maintenance 7.56 · 106–4.86 · 102 18
Cell cycle 5.07 · 104–4.05 · 102 4Tool) (Table 2). The majority of these SRF target genes are
found to be associated with cellular movement and cell
morphology. Other functions identified were cellular assem-
bly and organization, and cellular function and maintenance.
Previous work in other systems showed that Srf is able to reg-
ulate cell motility and related functions (reviewed in Olson
and Nordheim, 2010). Hence, the primary role of SRF in the
process of axis elongation seems to be controlling genes
involved in cell morphology and cellular movement.
To examine impaired cell morphology and migration in
Srfflex1/flex1; T(s)::Cre embryonic caudal ends, we analyzed cau-
dal explants in an ex vivo system. Cell adhesion and migration
of newly formed mesodermal cells emerging from the ps
requires the extracellular matrix protein Fibronectin (George
et al., 1997, 1993; Georges-Labouesse et al., 1996) and SRF-defi-
cient embryonic stem cells are capable of attaching to Fibro-
nectin-coated surfaces (Schratt et al., 2002). Using this
knowledge we performed explant culture assays on Fibronec-
tin-coated dishes to determine the migratory potential of
SRF-deficient mesoderm (Fig. 5A). Caudal explants from both
mutant and control embryos attached within one hour and
cells began to migrate away from the explant. After 48 h of
culture we measured the maximal distance between the
explant and the edge of the migrating cells and observed a
significant difference between SRF-deficient and control
embryos (Fig. 5B). The maximum distance observed was
604 lm ± 71 lm in mutant and 955 lm ± 59 lm in control
explants (n = 5) (student’s t-test: p = 2.9 · 105). Explants
migrate away after 5 h (300 min), while the cells from SRF
deficient explants remain in close proximity to the explant
tissue (Movie S1). As was seen in whole embryos, the number
of apoptotic cells was increased in mesenchymal cells around
the explants from the SRF mutants, while the number of
mitotic cells did not change (Fig. 5C and D). However, the
majority of cells that do not undergo apoptosis remain in
close proximity to the explant, exhibiting a reduced migration
capability (Movie S1). From these experiments we concluded
that SRF is required in vivo to control the cellular capacity
for migration during axis elongation.2.5. The formation of stress fibers and focal adhesions is
impaired in Srf-deficient embryo explants
In addition to impaired migration, we also observed that
caudal cells derived from SRF-deficient embryo explants
displayed differences in cell morphology as compared tog axial elongation, by GO analysis.
f genes Gene identities
Actb, Anxa2, Anxa3, Cnn2, Crk, Dstn, Egr1, Fhl1, Fhl2,
Fscn1, Pfn1, Srf, Tpm1, Tpm3, Vcl, Zyx
Actb, Anxa2, Cnn2, Crk, Dstn Egr1, Pfn1, Srf, Tpm1,
Tpm3, Vcl, Zyx
Actb, Anxa2, Cnn2, Crk, Dstn, Fhl1, Fhl2, Fscn1, Nlgn2,
Pdilm7, Pfn1, Srf, Tpm1, Tpm3, Vcl, Zyx
Actb, Anxa2, Anxa3, Cnn2, Crk, Dstn, Egr1, Fhl1, Fhl2,
Fscn1, Nlgn2, Pdilm7, Pfn1, Srf, Tpm1, Tpm3, Vcl, Zyx
Dstn, Egr1, Pfn1, Tpm1
Fig. 5 – SRF-deficiency results in impaired migration of mesodermal cells ex vivo. (A) Caudal ends were dissected from
Srfflex1/flex1; T(s)::Cre and Srfflex1/+; T(s)::Cre (control) embryos (representative embryos, level indicated by the dashed red lines),
divided along the midline, and plated with the medial surface facing down onto Fibronectin-coated dishes. After one hour the
explants adhered to the surface and cells began to spread. After two days, the maximum distance from the original explant
was measured (shown by the blue line). Scale bars (white) represent 150 lm. (B) Maximal distance between the border of the
occupied area and the original explant (n = 5) from Srfflex1/+; T(s)::Cre and Srfflex1/flex1; T(s)::Cre explants after 48 h. The s.d. is
given. (C) Representative LysoTracker Red staining of explants to visualize apoptotic cells. The white arrows point to
apoptotic cells. Scale bar represents 50 lm. (D) Representative H3S10P staining of explants to visualize proliferating cells. The
white arrows point to mitotic nuclei. Scale bar represents 50 lm.
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ples were long and spindle-shaped, typical hallmarks of
motile mesenchymal cells, the cells from SRF-deficient caudal
ends appeared small and rounded (Fig. 6A). Several of the
genes that we identified to be regulated by SRF in embryonic
caudal ends encode actin monomers (Actb, Acta2), proteins
involved in cytoskeletal actin organization (Tpm1, Tpm3,
Tpm4, Wdr1, Pdlim7, Cnn2, Dstn, Anxa2, Fscn1) or in the forma-
tion of focal adhesions (Zyx, Vcl, Fhl2, Crk). We reasoned that
the altered cell morphology observed in SRF-deficient
explants might be due to defective formation of actin stress
fibers and focal adhesions. To examine this possibility we
stained control and mutant explants with FITC conjugated
Phalloidin, to visualize F-actin fibers. The staining revealed
reduced F-actin level in cells originating from SRF-deficient
caudal ends as compared to controls (Fig. 6B), in agreement
with the observed decrease in expression of genes encoding
actin (Table 2). Furthermore, we noted a drastic difference in
the structure of the cytoskeleton. While cells from control
samples displayed stress fibers which traversed the entire cellbody, these structures were significantly reduced in cells from
SRF-deficient explants (Fig. 6B). Immunofluorescent staining
using an antibody against the focal adhesion protein Vinculin
further showed impaired focal adhesion formation in SRF-
deficient cells (Fig. 6C). These cells displayed a mesenchymal
character, as they were positive for Vimentin and no
membrane associated E-cadherin was detected (Fig. 6C). Since
stress fibers and focal adhesions are essential cytoskeletal
elements for migratory cells, their absence provides a
molecular explanation for the observed impairment of cell
migration in SRF-deficient embryo explants.
3. Discussion
SRF has previously been shown to be essential for neuro-
nal migration in the mouse forebrain (Alberti et al., 2005), as
well as for spreading, adhesion, and migration of murine ES
cells (Schratt et al., 2002). In both of these prior studies down-
regulation of genes encoding either actin monomers (Actb) or
proteins required for focal adhesion formation (Zyx, Vcl)
Fig. 6 – SRF-deficiency in mesodermal cells affects cell morphology and cytoskeletal arrangement. (A) Representative images
from caudal end explants from ex vivo migration assays. Images on the right show magnifications of the boxed areas in the
middle panels. (B) Representative fluorescence images from cells at the border of the explant culture after 48 h with Actin
visualized in the migratory cells using phalloidin (green) and nuclei with DAPI (blue). Scale bar represents 50 lm. (C)
Immunofluorescent staining of focal adhesions (Vinculin, red) and markers of mesenchymal cells (Vimentin, non-membrane
bound E-cadherin, red). Counterstaining was performed for Actin (phalloidin, green) and nuclei (DAPI, blue). Scale bar
represents 50 lm.
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defective formation of actin stress fibers and focal adhesion
plaques. Here we show that SRF is also essential for proper
migration of nascent mesoderm formed at the ps of mid-
gestation mouse embryos. We provide evidence that SRF is
required for reorganization of the actin cytoskeleton in nas-
cent mesoderm, and identify it as a crucial factor for A–P axis
elongation.
In searching for direct SRF target genes acting in axis
development on a genome-wide level, we identified several
novel SRF targets, along with a number of previouslydescribed targets (Fig. 3). Of note, v-crk sarcoma virus CT10
oncogene homolog (avian) (Crk1) and Fascin homolog 1 actin
bundling protein (Fscn1) encode proteins associated with cell
morphology and cellular motility. Fscn1 is widely expressed
throughout the embryo including in developing somites (De
Arcangelis et al., 2004), and has been implicated in tumor cell
migration and invasiveness (Grothey et al., 2000a, 2000b).
Inhibition of the Fascin–Actin interaction in C2C12 myoblast
cells interferes with cell migration and cytoskeletal
organization (Adams and Schwartz, 2000). Similarly, Crk
encodes a protein involved in focal adhesion formation and
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2001). Knockdown of Crk in NIH-3T3 fibroblasts resulted in
decreased PDGF-stimulated migratory ability (Antoku and
Mayer, 2009). These findings, together with our data, suggest
that downregulation of Fscn1 and/or Crk1 in SRF-deficient
mid-gestation embryos may significantly contribute to the
altered morphology and impaired migratory ability of meso-
dermal cells in these mutants.
Most of the genes we identified as direct SRF targets in the
ps-derived nascent mesoderm are related to cytoskeletal
actin reorganization and it was previously shown that genes
like Vcl, Cnn2, and others are regulated by SRF in combination
with the myocardin-related transcription factors MRTF-A and
MRTF-B (Olson and Nordheim, 2010). The activity of MRTF
cofactors, in turn, is controlled by Rho-dependent actin turn-
over (Miralles et al., 2003). In the ps of mid-gestational mouse
embryos, the disruption of E-cadherin-mediated epithelial
cell–cell contacts is indispensable for the ability of cells to
undergo EMT and gain motility. Previous reports have demon-
strated that the degradation of E-cadherin directly regulates
SRF–MRTF activity via the Rho family member RAC1 (Busche
et al., 2008). It is likely that the initial steps in cytoskeletal
reorganization required for mesoderm formation during axis
elongation utilize SRF in a complex with MRTF cofactors in
order to execute the complete program for adopting a migra-
tory capability.
A correlation between impaired mesodermal cell migra-
tion and arrested axis elongation has previously been shown
in several models. For example, treatment of chick embryos
with the cell motility inhibitors Y27632 and blebbistatin
causes delayed axis elongation (Be´naze´raf et al., 2010). In
migrating cells, the focal adhesion complexes are attached
to the ECM, and this attachment requires integrins. There
are several studies in mouse embryos showing that interfer-
ing with proper expression of either the ECM protein coding
gene Fibronectin or members of the Integrin family can cause
axis truncations (George et al., 1993; Georges-Labouesse
et al., 1996; Yang et al., 1999). In order to migrate, cells gener-
ate a force against the ECM by contracting actin stress fibers
that are attached to the focal adhesions (McHardy et al.,
2005). Consequently, impaired function of either Fibronectin
or members of the Integrin family affects mesodermal cell
migration. In fact, a mutation in the RGD motif of Fibronectin
(FnRGE/RGE) results in impaired axis elongation, which becomes
apparent at E9.0 due to a shift in integrin usage by mesoder-
mal cells at this stage (Giro´s et al., 2011). Interestingly, the
phenotype of FnRGE/RGE embryos closely resembles the pheno-
type of Srfflex1/flex1; T(s)::Cre embryos since, in addition to axis
truncation at E8.75–E9.0, both mutants have heart malforma-
tions. This suggests that the heart phenotype of Srfflex1/flex1;
T(s)::Cre embryos may also be partly a result of impaired cell
migration and not solely due to the role of SRF in heart
differentiation.
The gene Egr1, which is among the best studied SRF
targets, was found to be upregulated upon loss of SRF in the
caudal region of Srfflex1/flex1; T(s)::Cre embryos, suggesting that
Egr1 is repressed by SRF in this context. Similar observations
were reported by Sullivan and coworkers using a conditional
knock-out of Srf in macrophages (Sullivan et al., 2011). Egr1
is known to be involved in cellular growth control and cancontrol proliferation in hematopoietic stem cells (Min et al.,
2008). Thus, the downregulation of genes involved in
cytoskeletal reorganization into a mesenchymal, motile cell
type upon loss of Srf, and the simultaneous upregulation of
Egr1, might suggest that cell differentiation and cell prolifera-
tion also have to be precisely balanced during axis elongation.
It is noteworthy that, since we used T driven expression of
Cre to inactivate Srf, Srf should be inactivated in nascent
mesoderm beginning with primitive streak formation at
around E6.5 however, axis elongation was not visibly affected
until E9.0, similar to embryos homozygous for T/T
(Yanagisawa et al., 1981). This indicates a similar change in
requirement for Srf and T in early mesoderm formation, as
opposed to mesoderm formation at mid-gestation. Several
reports have indicated that the latter function of T comprises
the maintenance of axial stem cells, though there is not yet
direct proof for this proposition (for review see Kondoh and
Takemoto, 2012). Analogous to T, Srf might have an indirect
role in the maintenance of axial stem cells by regulating
migratory potential. In support of this hypothesis, it has been
suggested that loss of B1 Sox gene expression in multipoten-
tial paraxial precursor cells causes increased migration into
the mesodermal compartment and, thereby, increased pro-
duction of mesodermal tissue (Yoshida et al., 2014). Thus,
one might argue that the production of mesodermal tissue
decreases when migration is impaired; consequently causing
axis extension to arrest.
In summary, we show here that during axis elongation a
small subset of genes directly depend on SRF and these genes
associate primarily with migratory functions in nascent
mesodermal cells. This further highlights that, after the initi-
ation of EMT in which E-cadherin is degraded, nascent meso-
dermal cells have to adopt migratory capabilities in order to
properly form the A–P body axis.4. Materials and methods
4.1. In situ hybridization
Whole mount in situ hybridization was carried out using
the standard protocol described on the MAMEP website
(http://mamep.molgen.mpg.de). The Srf probe was generated
by PCR on cDNA from whole embryos (E9.5) and subcloned
into pBluescript II SK(+) (Stratagene) and covers the complete
coding region of Srf.4.2. Analysis of gene expression
Quantitative real-time PCR (qPCR): Total RNA was iso-
lated from embryos using the RNeasyMini Kit (Qiagen).
Reverse transcription of RNA into cDNA was performed
using the SuperScript II First-Strand Synthesis System
(Invitrogen). All procedures were performed according to
the manufacturer’s instructions. Gene expression was ana-
lyzed by qPCR using Power SYBR Green PCR Master Mix
(Applied Biosystems). The reactions were run in triplicate
on a StepOnePlus Real-Time PCR System, and the results
were analyzed using the StepOnePlus Software v2.0.2
(Applied Biosystems).
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sequences were used: Gapdh_fwd: TGAGAGAGGCCCAGCTAC
TC, Gapdh_rev: AGGGCTGCAGTCCGTATTTA; Hbms_fwd: CCT
GGGCGGAGTCATGTC, Hbms_rev: ACTCGAATCACCCTCATCTT
TGA; Srf-fwd: AGGGCTGCAGTCCGTATTTA, Srf_rev: AGGTATC
CCCCAACCCTTC; Wdr1_fwd: GGTCGCGTCACGTCACTT,
Wdr1_rev: CCCCCAGCTTTGACCATA; Vcl_fwd: ATCAATCCCTG
G CTTCACAC, Vcl_rev: TTTCAAAGT GCCCATGACAA; Zyx_fwd:
CAGTGCTTCACCTGTGTGGT, Zyx_rev: CCTTGGAGCGTATTGCT
TGT; Egr1_fwd: GGCCGGTCCTTCCATATT, Egr1_rev: CGAATCG
GCCTCTATTTCAA, Crk_fwd: CAGCTCTCCGTGAAGCCTAC,
Crk_rev: AGCCAAATCCAACCAAACAG; Fscn1_fwd: AGATGCTT
GGCTCCTGTCC, Fscn1_rev: GAGGTGTCTGGGAAGACGTG;
Nlgn2_fwd: CCTGAGCCCTGTAAGCAGAT, Nlgn2_rev: ATTGGAG
TCCGTGGCTGTAT.
Gene expression profiles of Srfflex1/flex1; T(s)::Cre caudal ends
at E8.5, 8.75 and 9.0 and those of the appropriate heterozy-
gous littermates were analyzed using Illumina whole-genome
expression arrays (Illumina Mouse Ref-8 v2.0). For each sam-
ple, four biological replicates were compared to four control
samples. RNA was isolated from embryonic caudal ends using
the RNeasy Mini Kit (Qiagen), and labeled using the Illumina
TotalPrep RNA Amplification Kit (Ambion). All procedures
were performed according to the manufacturer’s instructions.
1 lg of cRNA was hybridized to MouseRef-8 v2.0 Expression
BeadChip (Illumina). Arrays were scanned on the Illumina
BeadArray Reader and expression data were processed using
the lumiR/Bioconductor package (Du et al., 2008). Raw data
were analyzed using background subtraction (bgAdjust) and
the quantile normalization method. Differentially expressed
genes were identified using the limma1 package. Genes were
considered to be significantly dysregulated when they had a
fold change Plog20.4, p 6 0.05.
The GEO accession number for the expression data in this
paper is GSE44406.4.3. Chromatin immunoprecipitation and massive parallel
sequencing
For the SRF-ChIP we used a P19 cell line stably transfected
with a plasmid containing a neomycin resistance gene and a
CAGGS promoter-driven Srf transgene, coding for a SRF con-
taining an Avi-tag (SLNDIFEAQKIEW) at the C-terminus. The
cells were cultivated under standard conditions. At a conflu-
ence of 70–80% (approx. 2.5–4 · 107 cells on a 10 cm dish),
the cells were cross-linked with 0.75% formaldehyde for
10 min at room temperature, followed by a 5 min incubation
with glycine (0.125 M). Cells were scraped from the dish,
washed three times with PBS and lysed using 400 ll Upstate
lysis buffer at 7 C for 30 min in a thermoshaker at 750 rpm.
Chromatin was fragmented with a Branson Digital Sonifier
II W-450 (3 mm tip) using 6 · 10 s pulses with 50 s breaks
and fragmentation was verified on an agarose gel (mean size
300 bp). The sample was centrifuged (10,000 rcf, 1 min, 8 C)
and used for ChIP according to the Upstate protocol, using
2 lg of SRF antibody (Santa Cruz; sc-335 X) in a 400 ll total vol-
ume. To decrease nonspecific binding of DNA, the washing
times were increased from 8 min to 16 min. Massive parallelsequencing was performed by single read analysis with the
Illumina Genome Analyzer. Library preparation and sequenc-
ing was performed by the Next Generation Sequencing Core
Facility at Max-Planck Institute for Molecular Genetics
according to the Illumina ChIP-seq standard protocol.
Sequences were mapped against the mouse genome using
the bowtie software (Langmead et al., 2009) and peaks were
identified with SICER (Zang et al., 2009).4.4. Ex vivo migration assay
To analyze the migratory potential of SRF-deficient meso-
dermal cells, caudal ends from E9.5 Srfflex1/flex1; T(s)::Cre and
from control littermate embryos were dissected, split along
the midline and plated on l-slides (ibidi; Martinsried). The
slides had been coated one day earlier with the extracellular
matrix protein Fibronectin (Calbiochem #341631). For this pur-
pose, Fibronectin was diluted (1:100) with PBS, pipetted onto
the l-slides, and stored at 4 C. Shortly before usage, the
Fibronectin was washed off twice with PBS, and DMEM/10%
FBS was added. The embryonic tissue was placed cut side
down onto slides and attached within one hour. Next,
medium was removed until the tissue was at the air/liquid
interface and the explants were cultivated under standard
cell culture conditions. Medium was exchanged daily. After
two days, the maximal migration distance was measured
and explants were processed for immunofluorescence.
For the timelapse analysis the explants were analyzed on a
Zeiss LSM710NLO in an incubation chamber under 65% O2, 5%
CO2 and 30% N2 conditions in DMEM F12 media containing
5 mM Glucose, 1 mM Glutamine and 1% BSA (Lauschke
et al., 2013). A z-stack of 5 images with 2 · 2 overlapping tiles
was taken every 20 min using the ZEN software (Zeiss). Single
projected and stitched images were then used to compile the
movie using the ImageJ software.
4.5. Immunohistochemistry
Whole embryos were fixed in 4% paraformaldehyde
overnight. Following standard ethanol processing they were
embedded in paraffin and sectioned at 5 lm. Sections were
incubated with anti-Brachyury (1:400, R&D Systems), anti-E-
cadherin (1:200, BD Bioscience), anti-Vimentin (1:50, Santa
Cruz) and anti-H3S10P (1:500, Millipore) primary antibodies.
After counterstaining with secondary Cy3 coupled antibodies
(Life Technologies), sections were mounted using VECTA-
SHIELD mounting medium with DAPI (Vector Laboratories
Inc.).
Explants from the ex vivo assay were stained using Phalloi-
din–Fluorescein–isothiocyanate (FITC) conjugate (Sigma)
according to the manufacturer’s instructions at a dilution of
1:50 in PBS. Primary antibodies were used as described above
and focal adhesions were visualized using an antibody
against Vinculin (Abcam), according to standard procedures
at a dilution of 1:100.
For visualization of apoptotic cells, LysoTracker Red
DND-99 (Life Technologies) was used on the explants as
described previously (Zucker et al., 1999).
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Embryo cell suspensions were prepared by incubating
head or tail fractions, or single explants in 0.05% Trypsin/
EDTA for 5 min on ice with occasional shaking. Trypsin was
quenched by adding 5% BSA/PBS for 5 min and the single sus-
pension washed twice with PBS on ice. The Annexin-V-FLUOS
(Roche) staining kit was used according to the manufacturer’s
protocol. Prior to analysis on a FACS Aria II (BD Biosciences)
the suspension was filtered through a 30 lm mesh filter (BD
Biosciences). The data were analyzed using the FlowJo soft-
ware (Treestar).
Acknowledgments
We thank Achim Gossler for providing the T(s)::Cre mouse
strain. Thanks also to Manuela Scholze for help with embryo
isolation and Tracie Pennimpede for comments on the manu-
script. A.N. received funding by the DFG (Grant No. 120/12-4).
Appendix A. Supplementary data
Supplementary data associated with this article can be
found, in the online version, at http://dx.doi.org/10.1016/
j.mod.2014.07.001.R E F E R E N C E SAdams, J.C., Schwartz, M.A., 2000. Stimulation of fascin spikes by
thrombospondin-1 is mediated by the GTPases Rac and Cdc42.
J. Cell Biol. 150, 807–822.
Alberti, S., Krause, S.M., Kretz, O., Philippar, U., Lemberger, T.,
Casanova, E., Wiebel, F.F., Schwarz, H., Frotscher, M., Schu¨tz,
G., Nordheim, A., 2005. Neuronal migration in the murine
rostral migratory stream requires serum response factor. Proc.
Natl. Acad. Sci. USA 102, 6148–6153.
Antoku, S., Mayer, B.J., 2009. Distinct roles for Crk adaptor
isoforms in actin reorganization induced by extracellular
signals. J. Cell Sci. 122, 4228–4238.
Arsenian, S., Weinhold, B., Oelgeschla¨ger, M., Ru¨ther, U.,
Nordheim, A., 1998. Serum response factor is essential for
mesoderm formation during mouse embryogenesis. EMBO J.
17, 6289–6299.
Barron, M.R., Belaguli, N.S., Zhang, S.X., Trinh, M., Iyer, D., Merlo,
X., Lough, J.W., Parmacek, M.S., Bruneau, B.G., Schwartz, R.J.,
2005. Serum response factor, an enriched cardiac mesoderm
obligatory factor, is a downstream gene target for Tbx genes. J.
Biol. Chem. 280, 11816–11828.
Baum, B., Settleman, J., Quinlan, M.P., 2008. Transitions between
epithelial and mesenchymal states in development and
disease. Semin. Cell Dev. Biol. 19, 294–308.
Beddington, R.S., 1983. Histogenetic and neoplastic potential of
different regions of the mouse embryonic egg cylinder. J.
Embryol. Exp. Morphol. 75, 189–204.
Be´naze´raf, B., Francois, P., Baker, R.E., Denans, N., Little, C.D.,
Pourquie´, O., 2010. A random cell motility gradient
downstream of FGF controls elongation of an amniote embryo.
Nature 466, 248–252.
Ben-Haim, N., Lu, C., Guzman-Ayala, M., Pescatore, L., Mesnard,
D., Bischofberger, M., Naef, F., Robertson, E.J., Constam, D.B.,
2006. The nodal precursor acting via activin receptors inducesmesoderm by maintaining a source of its convertases and
BMP4. Dev. Cell 11, 313–323.
Busche, S., Descot, A., Julien, S., Genth, H., Posern, G., 2008.
Epithelial cell–cell contacts regulate SRF-mediated
transcription via Rac-actin-MAL signalling. J. Cell Sci. 121,
1025–1035.
Catala, F., Wanner, R., Barton, P., Cohen, A., Wright, W.,
Buckingham, M., 1995. A skeletal muscle-specific enhancer
regulated by factors binding to E and CArG boxes is present in
the promoter of the mouse myosin light-chain 1A gene. Mol.
Cell. Biol. 15, 4585–4596.
Ciruna, B., Rossant, J., 2001. FGF signaling regulates mesoderm
cell fate specification and morphogenetic movement at the
primitive streak. Dev. Cell 1, 37–49.
Croissant, J.D., Kim, J.H., Eichele, G., Goering, L., Lough, J., Prywes,
R., Schwartz, R.J., 1996. Avian serum response factor
expression restricted primarily to muscle cell lineages is
required for alpha-actin gene transcription. Dev. Biol. 177, 250–
264.
Cunningham, T.J., Zhao, X., Duester, G., 2011. Uncoupling of
retinoic acid signaling from tailbud development before
termination of body axis extension. Genesis 49, 776–783.
De Arcangelis, A., Georges-Labouesse, E., Adams, J.C., 2004.
Expression of fascin-1, the gene encoding the actin-bundling
protein fascin-1, during mouse embryogenesis. Gene Exp. Pat.
4, 637–643.
Du, P., Kibbe, W.A., Lin, S.M., 2008. Lumi: a pipeline for processing
Illumina microarray. Bioinformatics 24, 1547–1548.
Feller, S.M., 2001. Crk family adaptors-signalling complex
formation and biological roles. Oncogene 20, 6348–6371.
Feller, J., Schneider, A., Schuster-Gossler, K., Gossler, A., 2008.
Noncyclic Notch activity in the presomitic mesoderm
demonstrates uncoupling of somite compartmentalization
and boundary formation. Genes Dev. 22, 2166–2171.
George, E.L., Georges-Labouesse, E.N., Patel-King, R.S., Rayburn,
H., Hynes, R.O., 1993. Defects in mesoderm, neural tube and
vascular development in mouse embryos lacking fibronectin.
Development 119, 1079–1091.
George, E.L., Baldwin, H.S., Hynes, R.O., 1997. Fibronectins are
essential for heart and blood vessel morphogenesis but are
dispensable for initial specification of precursor cells. Blood
90, 3073–3081.
Georges-Labouesse, E.N., George, E.L., Rayburn, H., Hynes, R.O.,
1996. Mesodermal development in mouse embryos mutant for
fibronectin. Dev. Dyn. 207, 145–156.
Giro´s, A., Grgur, K., Gossler, A., Costell, M., 2011. a5b1 integrin-
mediated adhesion to fibronectin is required for axis
elongation and somitogenesis in mice. PLoS One 6, e22002.
Grothey, A., Hashizume, R., Ji, H., Tubb, B.E., Patrick, C.W., Yu, D.,
Mooney, E.E., McCrea, P.D., 2000a. C-erbB-2/HER-2 upregulates
fascin, an actin-bundling protein associated with cell motility,
in human breast cancer cell lines. Oncogene 19, 4864–4875.
Grothey, A., Hashizume, R., Sahin, A.A., McCrea, P.D., 2000b.
Fascin, an actin-bundling protein associated with cell motility,
is upregulated in hormone receptor negative breast cancer. Br.
J. Cancer 83, 870–873.
Herrmann, B.G., 1991. Expression pattern of the Brachyury gene in
whole-mount TWis/TWis mutant embryos. Development 917,
913–917.
Johansen, F.E., Prywes, R., 1995. Serum response factor:
transcriptional regulation of genes induced by growth factors
and differentiation. Biochim. Biophys. Acta 1242, 1–10.
Jung, C., Lim, J.H., Choi, Y., Kim, D., Kang, K.J., Noh, S.-M., Im, D.-S.,
2010. Enigma negatively regulates p53 through MDM2 and
promotes tumor cell survival in mice. J. Clin. Invest. 120, 4493–
4506.
Kemler, R., Hierholzer, A., Kanzler, B., Kuppig, S., Hansen, K.,
Taketo, M.M., de Vries, W.N., Knowles, B.B., Solter, D., 2004.
34 M E C H A N I S M S O F D E V E L O P M E N T 1 3 3 ( 2 0 1 4 ) 2 3 –3 5Stabilization of beta-catenin in the mouse zygote leads to
premature epithelial–mesenchymal transition in the epiblast.
Development 131, 5817–5824.
Kondoh, H., Takemoto, T., 2012. Axial stem cells deriving both
posterior neural and mesodermal tissues during gastrulation.
Curr. Opin. Genet. Dev. 22, 374–380.
Langmead, B., Trapnell, C., Pop, M., Salzberg, S.L., 2009. Ultrafast
and memory-efficient alignment of short DNA sequences to
the human genome. Genome Biol. 10, R25.
Lauschke, V.M., Tsiairis, C.D., Franc¸ois, P., Aulehla, A., 2013.
Scaling of embryonic patterning based on phase-gradient
encoding. Nature 493, 101–105.
Levayer, R., Lecuit, T., 2008. Breaking down EMT. Nat. Cell Biol. 10,
757–759.
Lim, J., Thiery, J.P., 2012. Epithelial–mesenchymal transitions:
insights from development. Development 139, 3471–3486.
Luxenburg, C., Pasolli, H.A., Williams, S.E., Fuchs, E., 2011.
Developmental roles for Srf, cortical cytoskeleton and cell
shape in epidermal spindle orientation. Nat. Cell Biol. 13, 203–
214.
Martin, B.L., Kimelman, D., 2012. Canonical Wnt signaling
dynamically controls multiple stem cell fate decisions during
vertebrate body formation. Dev. Cell 22, 223–232.
McBurney, M.W., 1993. P19 embryonal carcinoma cells. Int. J. Dev.
Biol. 37, 135–140.
McHardy, L.M., Warabi, K., Andersen, R.J., Roskelley, C.D., Roberge,
M., 2005. Strongylophorine-26, a Rho-dependent inhibitor of
tumor cell invasion that reduces actin stress fibers and
induces nonpolarized lamellipodial extensions. Mol. Cancer
Ther. 4, 772–778.
Miano, J.M., 2003. Serum response factor: toggling between
disparate programs of gene expression. J. Mol. Cell. Cardiol. 35,
577–593.
Miano, J.M., 2008. Deck of CArGs. Circ. Res. 103, 13–15.
Min, I.M., Pietramaggiori, G., Kim, F.S., Passegue´, E., Stevenson,
K.E., Wagers, A.J., 2008. The transcription factor EGR1 controls
both the proliferation and localization of hematopoietic stem
cells. Cell Stem Cell 2, 380–391.
Miralles, F., Posern, G., Zaromytidou, A., Treisman, R., 2003. Actin
dynamics control SRF activity by regulation of its coactivator
MAL. Cell 113, 329–342.
Mohun, T.J., Chambers, A.E., Towers, N., Taylor, M.V., 1991.
Expression of genes encoding the transcription factor SRF
during early development of Xenopus laevis: identification of a
CArG box-binding activity as SRF. EMBO J. 10, 933–940.
Moiseyeva, E.P., Weller, P.A., Zhidkova, N.I., Corben, E.B., Patel, B.,
Jasinska, I., Koteliansky, V.E., Critchley, D.R., 1993.
Organization of the human gene encoding the cytoskeletal
protein vinculin and the sequence of the vinculin promoter. J.
Biol. Chem. 268, 4318–4325.
Nakaya, Y., Sheng, G., 2008. Epithelial to mesenchymal transition
during gastrulation: an embryological view. Dev. Growth
Differ. 50, 755–766.
Norman, C., Runswick, M., Pollock, R., Treisman, R., 1988.
Isolation and properties of cDNA clones encoding SRF, a
transcription factor that binds to the c-fos serum response
element. Cell 55, 989–1003.
Olson, E.N., Nordheim, A., 2010. Linking actin dynamics and gene
transcription to drive cellular motile functions. Nat. Rev. Mol.
Cell Biol. 11, 353–365.
O’Sullivan, N.C., Pickering, M., Di Giacomo, D., Loscher, J.S.,
Murphy, K.J., 2010. Mkl transcription cofactors regulate
structural plasticity in hippocampal neurons. Cereb. Cortex 20,
1915–1925.
Parlakian, A., Tuil, D., Hamard, G., Tavernier, G., Hentzen, D.,
Concordet, J.-P., Paulin, D., Li, Z., Daegelen, D., 2004. Targeted
inactivation of serum response factor in the developing heartresults in myocardial defects and embryonic lethality. Mol.
Cell. Biol. 24, 5281–5289.
Philippar, U., Schratt, G., Dieterich, C., Mu¨ller, J.M., Galgo´czy, P.,
Engel, F.B., Keating, M.T., Gertler, F., Schu¨le, R., Vingron, M.,
Nordheim, A., 2004. The SRF target gene Fhl2 antagonizes
RhoA/MAL-dependent activation of SRF. Mol. Cell 16, 867–880.
Schlesinger, J., Schueler, M., Grunert, M., Fischer, J.J., Zhang, Q.,
Krueger, T., Lange, M., To¨njes, M., Dunkel, I., Sperling, S.R.,
2011. The cardiac transcription network modulated by Gata4,
Mef2a, Nkx2.5, Srf, histone modifications, and microRNAs.
PLoS Genet. 7, e1001313.
Schratt, G., Philippar, U., Berger, J., Schwarz, H., Heidenreich, O.,
Nordheim, A., 2002. Serum response factor is crucial for actin
cytoskeletal organization and focal adhesion assembly in
embryonic stem cells. J. Cell Biol. 156, 737–750.
Schratt, G., Philippar, U., Hockemeyer, D., Schwarz, H., Alberti, S.,
Nordheim, A., 2004. SRF regulates Bcl-2 expression and
promotes cell survival during murine embryonic
development. EMBO J. 23, 1834–1844.
Selvaraj, A., Prywes, R., 2004. Expression profiling of serum
inducible genes identifies a subset of SRF target genes that are
MKL dependent. BMC Mol. Biol. 5, 13.
Shore, P., Sharrocks, A.D., 1995. The MADS-box family of
transcription factors. Eur. J. Biochem. 229, 1–13.
Spencer, J.a., Misra, R.P., 1999. Expression of the SRF gene occurs
through a Ras/Sp/SRF-mediated-mechanism in response to
serum growth signals. Oncogene 18, 7319–7327.
Sullivan, A.L., Benner, C., Heinz, S., Huang, W., Xie, L., Miano, J.M.,
Glass, C.K., 2011. Serum response factor utilizes distinct
promoter- and enhancer-based mechanisms to regulate
cytoskeletal gene expression in macrophages. Mol. Cell. Biol.
31, 861–875.
Sun, Q., Chen, G., Streb, J.W., Long, X., Yang, Y., Stoeckert, C.J.,
Miano, J.M., 2006. Defining the mammalian CArGome. Genome
Res. 16, 197–207.
Takada, S., Stark, K.L., Shea, M.J., Vassileva, G., McMahon, J.A.,
McMahon, A.P., 1994. Wnt-3a regulates somite and tailbud
formation in the mouse embryo. Genes Dev. 8, 174–189.
Van der Heyden, M.A.G., Defize, L.H.K., 2003. Twenty one years of
P19 cells: what an embryonal carcinoma cell line taught us
about cardiomyocyte differentiation. Cardiovasc. Res. 58, 292–
302.
Watson, D.K., Robinson, L., Hodge, D.R., Kola, I., Papas, T.S., Seth,
A., 1997. FLI1 and EWS-FLI1 function as ternary complex
factors and ELK1 and SAP1a function as ternary and
quaternary complex factors on the Egr1 promoter serum
response elements. Oncogene 14, 213–221.
Wiebel, F.F., Rennekampff, V., Vinterstein, K., Nordheim, A., 2002.
Generation of mice carrying conditional knockout alleles for
the transcription factor SRF. Nucleic Acids Res. 32, 124–126.
Wilkinson, D.G., Bhatt, S., Herrmann, B.G., 1990. Expression
pattern of the mouse T gene and its role in mesoderm
formation. Nature 343, 657–659.
Wilson, V., Olivera-Martinez, I., Storey, K.G., 2009. Stem cells,
signals and vertebrate body axis extension. Development 136,
1591–1604.
Yanagisawa, K.O., Fujimoto, H., Urushihara, H., 1981. Effects of
the brachyury (T) mutation on morphogenetic movement in
the mouse embryo. Dev. Biol. 87, 242–248.
Yang, J.T., Bader, B.L., Kreidberg, J.A., Ullman-Cullere´, M.,
Trevithick, J.E., Hynes, R.O., 1999. Overlapping and
independent functions of fibronectin receptor integrins in
early mesodermal development. Dev. Biol. 215, 264–277.
Yeom, Y.I., Fuhrmann, G., Ovitt, C.E., Brehm, A., Ohbo, K., Gross,
M., Hu¨bner, K., Scho¨ler, H.R., 1996. Germline regulatory
element of Oct-4 specific for the totipotent cycle of embryonal
cells. Development 122, 881–894.
M E C H A N I S M S O F D E V E L O P M E N T 1 3 3 ( 2 0 1 4 ) 2 3 –3 5 35Yoshida, M., Uchikawa, M., Rizzoti, K., Lovell-Badge, R., Takemoto,
T., Kondoh, H., 2014. Regulation of mesodermal precursor
production by low-level expression of B1 Sox genes in the
caudal lateral epiblast. Mech. Dev. 132, 59–68.
Zang, C., Schones, D.E., Zeng, C., Cui, K., Zhao, K., Peng, W., 2009.
A clustering approach for identification of enriched domains
from histone modification ChIP-Seq data. Bioinformatics 25,
1952–1958.Zohn, I.E., Li, Y., Skolnik, E.Y., Anderson, K.V., Han, J., Niswander,
L., 2006. P38 and a p38-interacting protein are critical for
downregulation of E-cadherin during mouse gastrulation. Cell
125, 957–969.
Zucker, R.M., Hunter, E.S., Rogers, J.M., 1999. Apoptosis and
morphology in mouse embryos by confocal laser scanning
microscopy. Methods 18, 473–480.
